The U.S. Food and Drug Administration is bargaining with the pharmaceutical industry for an increase in fees, giving the industry a greater role in shaping the priorities of its regulator, The Wall Street Journal said on Friday.
The newspaper cited people with knowledge of the matter saying the agency is likely to win some concessions, including new funding for drug safety, partly because of pressure on drug companies from Congress.
The Journal said steadily rising payments by drug makers -- $232 million in fiscal 2004 -- now fund more than half the agency's drug-review process, enhancing the importance of the talks.
Labels: No Prescription, Online Pharmacy, Prescription Drugs
# posted by Network @ 5:52 PM
